DUBLIN--(BUSINESS WIRE)--The "Global Pharma Clinical Trial Services - Procurement Market Intelligence Report" report has been added to ResearchAndMarkets.com's offering.
The report provides actionable insights to improve source-to-contract cycle performance in the Global Pharma Clinical Trial Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
One of the best procurement practices for the buyers is to engage with service providers that deal with adaptive trial designs.
According to the report, one of the key growth contributors for the global pharma clinical trial services market is the rise in outsourcing of drug development to CROs by biopharmaceutical companies.
Further, the report states that a major procurement challenge experienced by the buyers is the inconsistency in the quality of services in case of engagement with multiple suppliers.
Key Topics Covered
1. Category at a Glance
2. Scope of the Report
3. Market Insights
4. Supply Market Insights
5. Pricing Insights
6. Procurement Insights
7. Top Five Suppliers
For more information about this report visit https://www.researchandmarkets.com/research/d7xt32/pharma_clinical?w=4